Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1950 6
1951 4
1952 1
1953 1
1954 2
1955 2
1956 2
1957 2
1958 2
1959 3
1961 3
1962 3
1963 5
1964 2
1965 1
1966 2
1967 3
1968 5
1971 1
1975 1
1980 1
1988 1
1989 1
1990 1
1991 1
1994 1
1995 1
1996 1
1997 2
1998 5
1999 5
2000 3
2002 1
2003 2
2005 1
2006 4
2007 3
2008 4
2009 5
2010 4
2011 2
2012 8
2013 6
2014 3
2015 7
2016 7
2017 6
2018 5
2019 4
2020 15
2021 8
2022 8
2023 5
2024 8
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.
Blackstone J, Williams T, Nicholas JM, Bordea E, De Angelis F, Bianchi A, Calvi A, Doshi A, John N, Apap Mangion S, Wade C, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson N, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri S, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Nixon SJ, Beveridge J, Hawton A, Tebbs S, Braisher M, Giovannoni G, Ciccarelli O, Greenwood J, Thompson AJ, Hunter R, Pavitt S, Pearson O, Evangelou N, Sharrack B, Galea I, Chandran S, Ford HL, Frost C, Chataway J. Blackstone J, et al. Among authors: silber e. BMJ Open. 2024 Sep 16;14(9):e086414. doi: 10.1136/bmjopen-2024-086414. BMJ Open. 2024. PMID: 39284697 Free PMC article.
Osmotic demyelination syndrome.
Abbott R, Silber E, Felber J, Ekpo E. Abbott R, et al. Among authors: silber e. BMJ. 2005 Oct 8;331(7520):829-30. doi: 10.1136/bmj.331.7520.829. BMJ. 2005. PMID: 16210283 Free PMC article. No abstract available.
Osteoporosis in multiple sclerosis.
Hearn AP, Silber E. Hearn AP, et al. Among authors: silber e. Mult Scler. 2010 Sep;16(9):1031-43. doi: 10.1177/1352458510368985. Epub 2010 Jun 15. Mult Scler. 2010. PMID: 20551086 Review.
Diabetes and neurology: hemichorea-hemiballism in hyperglycaemia.
Galloway KY, Younus O, Quattrocchi G, Raheem B, Dervenoulas G, Silber E. Galloway KY, et al. Among authors: silber e. Clin Med (Lond). 2020 Mar;20(Suppl 2):s21-s22. doi: 10.7861/clinmed.20-2-s21. Clin Med (Lond). 2020. PMID: 32409348 Free PMC article. No abstract available.
Eisenmenger complex.
Christ ML, Silber E, Shaffer AB, Pick A, Levin B. Christ ML, et al. Among authors: silber e. Am Heart J. 1971 Aug;82(2):236-51. doi: 10.1016/0002-8703(71)90272-9. Am Heart J. 1971. PMID: 4933981 No abstract available.
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study.
Muraro PA, Zito A, Signori A, Sormani MP, Rigoni E, Pollidoro F, Bergamaschi R, Mariottini A, Malik O, Nandoskar A, Singh-Curry V, Mehra V, Kazmi M, Gabriel I, Silber E, Nicholas R, Scalfari A. Muraro PA, et al. Among authors: silber e. Ann Neurol. 2025 Aug;98(2):294-307. doi: 10.1002/ana.27247. Epub 2025 Apr 19. Ann Neurol. 2025. PMID: 40251896 Free PMC article.
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.
Brittain G, Petrie J, Duffy KEM, Glover R, Hullock K, Papaioannou D, Roldan E, Beecher C, Bursnall M, Ciccarelli O, Coles AJ, Cooper C, Giovannoni G, Gabriel I, Kazmi M, Kyriakou C, Nicholas R, Paling D, Peniket A, Scolding N, Silber E, de Silva T, Venneri A, Walters SJ, Young C, Muraro PA, Sharrack B, Snowden JA; StarMS trial team. Brittain G, et al. Among authors: silber e. BMJ Open. 2024 Feb 5;14(2):e083582. doi: 10.1136/bmjopen-2023-083582. BMJ Open. 2024. PMID: 38316583 Free PMC article.
187 results